You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


Immunologic Disorders

Citations 121-130 of 219 total displayed.

Past content (since Jan 1998):

Studies
Treatment of Pemphigus Vulgaris and Pemphigus Foliaceus With Mycophenolate Mofetil
Daniel Mimouni; Grant J. Anhalt; Deborah L. Cummins; David J. Kouba; Jennifer E. Thorne; H. Carlos Nousari
Arch Dermatol 2003; 139: 739-742. [Abstract] [Full text] [PDF]  

Correspondence
Topical Tacrolimus Is a Useful Adjunctive Therapy for Bullous Pemphigoid
Josephine Chu; Maria Bradley; M. Peter Marinkovich
Arch Dermatol 2003; 139: 813-815. [Extract] [Full text] [PDF]  

Studies
A Double-blind Randomized Trial of 0.1% Tacrolimus vs 0.05% Clobetasol for the Treatment of Childhood Vitiligo
Veronica Lepe; Benjamin Moncada; Juan Pablo Castanedo-Cazares; Maria Bertha Torres-Alvarez; Carlos A. Ortiz; Antonio B. Torres-Rubalcava
Arch Dermatol 2003; 139: 581-585. [Abstract] [Full text] [PDF]  

Editorials
Childhood Vitiligo and Tacrolimus: Immunomodulating Treatment for an Autoimmune Disease
Heidi Plettenberg; Till Assmann; Thomas Ruzicka
Arch Dermatol 2003; 139: 651-654. [Extract] [Full text] [PDF]  

Studies
9-cis-Retinoic Acid Capsules in the Treatment of AIDS-Related Kaposi Sarcoma: Results of a Phase 2 Multicenter Clinical Trial
David M. Aboulafia; Dorece Norris; David Henry; Ronald J. Grossman; James Thommes; Denise Bundow; Richard C. Yocum; Victor Stevens
Arch Dermatol 2003; 139: 178-186. [Abstract] [Full text] [PDF]  

The Cutting Edge
Topical Targretin and Intralesional Interferon Alfa for Cutaneous Lymphoma of the Scalp
Jennifer T. Trent; Paolo Romanelli; Francisco A. Kerdel
Arch Dermatol 2002; 138: 1421-1423. [Extract] [Full text] [PDF]  

Observations
Circulating CD4+CD7- Lymphocyte Burden and Rapidity of Response: Predictors of Outcome in the Treatment of Sézary Syndrome and Erythrodermic Mycosis Fungoides With Extracorporeal Photopheresis
Seth R. Stevens; Elma D. Baron; Susan Masten; Kevin D. Cooper
Arch Dermatol 2002; 138: 1347-1350. [Abstract] [Full text] [PDF]  

Observations
Long-term Remission After Allogeneic Hematopoietic Stem Cell Transplantation for Refractory Cutaneous T-Cell Lymphoma
Joan Guitart; Scott C. Wickless; Yu Oyama; Timothy M. Kuzel; Steve T. Rosen; Ann Traynor; Richard Burt
Arch Dermatol 2002; 138: 1359-1365. [Abstract] [Full text] [PDF]  

Corrections
Error in Author Degrees
Arch Dermatol 2002; 138: 1386. [Full text] [PDF]  

The Cutting Edge
Treatment of Stage IA Cutaneous T-Cell Lymphoma With Topical Application of the Immune Response Modifier Imiquimod
Karen Rebecca Suchin; Jacqueline M. Junkins-Hopkins; Alain H. Rook; Hospital of the University of Pennsylvania, Philadelphia
Arch Dermatol 2002; 138: 1137-1139. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

 Collections
 •Sign up for Topic Collection Alerts
 •Topic Collections Home
 • Show Immunologic Disorders
 collections from JAMA & Archives Journals.
 •Related collections:
  •Immunology
  •Allergy
  •Immunologic Disorders
  •Immunology, Other
Advertisement





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.